These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2373039)

  • 1. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
    Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
    Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
    Boussiotis VA; Pangalis GA
    Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
    Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
    Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
    Demeter J; Paloczi K; Bibok G; Lehoczky D
    Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
    McSweeney EN; Giles FJ; Worman CP; Jewel AP; Tsakona CP; Hoffbrand AV; Mehta AB; Newland AC; Cawley JC; Galvani D
    Br J Haematol; 1993 Sep; 85(1):77-83. PubMed ID: 8251412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.
    Langenmayer I; Nerl C; Knauf W; Dempster S; Hallek M; Adorf D; Dietzfelbinger H; Busch R; Ziegler-Heitbrock HW; Thiel E; Emmerich B
    Br J Haematol; 1996 Aug; 94(2):362-9. PubMed ID: 8759897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial with alpha 2b-interferon in 26 stage A untreated B-chronic lymphocytic leukemia patients.
    Boussiotis VA; Pangalis GA
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):471-3. PubMed ID: 3065744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.
    Villamor N; Reverter JC; Montserrat E; Urbano-Ispízua A; Vives-Corrons JL; Rozman C
    Leukemia; 1992 Jun; 6(6):547-52. PubMed ID: 1376376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
    Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
    Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
    Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
    Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
    Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation.
    Morabito F; Callea V; Oliva B; Stelitano C; Vincelli I; Molica S; Alberti A; Brugiatelli M; Nobile F
    Leukemia; 1993 Mar; 7(3):366-71. PubMed ID: 7680399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia.
    Klener P; Háber J; Hausner P
    Neoplasma; 1989; 36(2):215-20. PubMed ID: 2716926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.
    O'Brien S; Kantarjian H; Beran M; Robertson LE; Koller C; Lerner S; Keating MJ
    Blood; 1995 Aug; 86(4):1298-300. PubMed ID: 7632936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
    Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
    N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of treatment with recombinant interferon alfa on natural killer activity in patients with chronic type B lymphatic leukemia].
    Villamor N; Montserrat E; Urbano-Ispízua A; Ribera JM; Rovira M; Vives Corrons JL; Rozman C
    Sangre (Barc); 1989 Dec; 34(6):485-8. PubMed ID: 2629126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S; Alberti A
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon-alpha treatment of the Churg-Strauss syndrome].
    Reissig A; Förster M; Mock B; Schilder C; Kroegel C
    Dtsch Med Wochenschr; 2003 Jul; 128(27):1475-8. PubMed ID: 12840770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin lesion's treatment with alfa interferon in a patient with B-CLL.
    Panteli K; Katsanos KH; Kitsanou M; Nakou K; Alexandridis G; Bourantas KL
    J Exp Clin Cancer Res; 2000 Mar; 19(1):123-4. PubMed ID: 10840947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.